The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a promising advance. Unlike subcutaneous injections, this approach offers a more convenient way to deliver GLP-1 https://ammargjmp944907.tkzblog.com/40727449/glp-1-patches-a-novel-approach-to-glucose-control